Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 15, 2024

Primary Completion Date

December 15, 2025

Study Completion Date

December 15, 2025

Conditions

Chronic Hepatitis B

Interventions

DRUG

Sintilimab

100mg/10ml/1bottle

DRUG

NAs

tablets

DRUG

Peg-IFNα-2b

180ug/0.5ml/1bottle

Trial Locations (1)

RECRUITING

the Fifth Medical Center, Chinese PLA General Hospital, Beijing

All Listed Sponsors

lead

Beijing 302 Hospital

OTHER